![](https://images.newscientist.com/wp-content/uploads/2024/06/10142958/SEI_208146396.jpg)
Semaglutide, sold as Ozempic or Wegovy, is given as an injection to treat diabetes or promote weight loss
Marc Bruxelle / Alamy Stock Photo
The weight loss and diabetes drug semaglutide may also help people reduce their alcohol intake.
A study of nearly 700,000 people who were taking the medicine, sold under the brand names Wegovy and Ozempic, adds to a growing body of evidence suggesting the drug may have wider uses in people with a range of addictions.
“This is the strongest evidence yet in humans,”…